Android Apple

Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

By Yahoo! Finance   |   1 month ago
Even after rising 13% this past week, Clearside Biomedical (NASDAQ:CLSD) shareholders are still down 77% over the past three years

Despite Clearside Biomedical, Inc.'s recent 13% share price increase, its three-year returns show a significant decline of 77%. The company's revenue has been shrinking by 38% annually, impacting its share price negatively.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.